Conmed Corp. - Ordinary Shares (NASDAQ: CNMD) stock closed at 100.51 per share at the end of the most recent trading day (a 3.61% change compared to the prior day closing price) with a volume of 273.98K shares and market capitalization of 2.97B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3400 people. Conmed Corp. - Ordinary Shares CEO is Curt R. Hartman.

The one-year performance of Conmed Corp. - Ordinary Shares stock is -20.44%, while year-to-date (YTD) performance is -29.1%. CNMD stock has a five-year performance of 102.52%. Its 52-week range is between 87.24 and 159.11, which gives CNMD stock a 52-week price range ratio of 14.14%

Conmed Corp. - Ordinary Shares currently has a PE ratio of 45.80, a price-to-book (PB) ratio of 3.59, a price-to-sale (PS) ratio of 3.68, a price to cashflow ratio of 35.50, a PEG ratio of 2.32, a ROA of 3.94%, a ROC of 6.24% and a ROE of 9.18%. The company’s profit margin is 7.04%, its EBITDA margin is 17.70%, and its revenue ttm is $765.12 Million , which makes it $25.91 revenue per share.

Of the last four earnings reports from Conmed Corp. - Ordinary Shares, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.76 for the next earnings report. Conmed Corp. - Ordinary Shares’s next earnings report date is -.

The consensus rating of Wall Street analysts for Conmed Corp. - Ordinary Shares is Moderate Buy (1.83), with a target price of $144, which is +47.84% compared to the current price. The earnings rating for Conmed Corp. - Ordinary Shares stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Conmed Corp. - Ordinary Shares has a dividend yield of 0.84% with a dividend per share of $0.80 and a payout ratio of 44.00%.

Conmed Corp. - Ordinary Shares has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.11, ATR14 : 3.41, CCI20 : 32.35, Chaikin Money Flow : 0.16, MACD : -0.12, Money Flow Index : 50.97, ROC : -1.61, RSI : 52.16, STOCH (14,3) : 54.60, STOCH RSI : 0.74, UO : 49.45, Williams %R : -45.40), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Conmed Corp. - Ordinary Shares in the last 12-months were: Barbara J Schwarzentraub (Option Excercise at a value of $0), Brent Lalomia (Option Excercise at a value of $0), Brian P. Concannon (Option Excercise at a value of $518 729), Brian P. Concannon (Sold 12 984 shares of value $1 762 324 ), Charles M. Farkas (Option Excercise at a value of $0), Curt R. Hartman (Sold 0 shares of value $-3 976 205 ), Curt R. Hartman (Sold 5 000 shares of value $664 540 ), Daniel S. Jonas (Sold 0 shares of value $-2 874 836 ), Daniel S. Jonas (Sold 33 957 shares of value $4 850 850 ), David M. Bronson (Option Excercise at a value of $0), Jaclyn Peterson (Option Excercise at a value of $0), Jerome J Lande (Option Excercise at a value of $0), Jerome J Lande (Sold 7 521 shares of value $870 493 ), John E. Kennedy (Option Excercise at a value of $1 830 003), John E. Kennedy (Sold 32 272 shares of value $4 602 438 ), John L. Workman (Option Excercise at a value of $0), Johonna Pelletier (Sold 0 shares of value $-674 414 ), Johonna Pelletier (Sold 9 197 shares of value $1 421 102 ), LaVerne Council (Option Excercise at a value of $0), Mark E. Tryniski (Option Excercise at a value of $855 506), Mark E. Tryniski (Sold 12 420 shares of value $1 943 745 ), Martha Goldberg Aronson (Option Excercise at a value of $0), Patrick J. Beyer (Option Excercise at a value of $4 805 721), Patrick J. Beyer (Sold 42 729 shares of value $6 270 747 ), Stanley W. Peters (Sold 0 shares of value $-1 001 269 ), Stanley W. Peters (Sold 24 700 shares of value $3 744 890 ), Todd W. Garner (Option Excercise at a value of $425 124), Todd W. Garner (Sold 13 734 shares of value $1 693 093 )